Vendor source

Reviewed 11 May 2026

Completeness Strong (69%)

Neurocloud SISCOM

Qubiotech

Automatic co-registration of the SPECT images with the patient's MRI. Interictal SPECT image subtraction is applied on the ictal image and the epileptogenic zone is identified. The SISCOM procedure is recommended by the EANM in the study of epilepsy, and provides high sensitivity and specificity in the localization of the epileptogenic focus. Neurocloud SISCOM provides a parametric map of the voxels identified as epileptogenic zone on MRI, data tables with the maximum Z-Score for each region of interest (ROI) as well as the percentage overlap of the focus and the SPECT - MRI fusion image.

No papers to support — we monitor for new evidence.

Key Features

  • Automatic co-registration SPECT-MRI
  • Identification of epileptogenic focus
  • Interictal spect subtraction ictal image
  • Percentage overlap of the focus

General Information

Product name

Neurocloud SISCOM

Company

Modality

MR, SPECT

Main task

Not specified

Subspeciality

Neuro

Disease targeted

Epilepsy

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class I

Verified by Health AI Register

Other certifications

Not specified

Evidence & Research

Technical Specifications

Patient population age

Not specified

Input

SPECT 3D Acquisition with 99mTc HMPAO, OSEM (recommended) or FBP reconstruction.

Input format

DICOM

Output

Co-registered SPECT-MRI, interictal SPECT substraction image, table with the maximum Z-Score, percentage overlap of the focus

Output format

DICOM, EXCEL, NIFTI, PDF

Integration

Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform, Stand-alone webbased

Deployment

Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)

Trigger for analysis

On demand, triggered by a user through e.g. a button click, image upload

Processing time

1 - 10 minutes

Population

Patients from 16 to 90 yo.

Market Presence

On market since

01-2018

AI Platforms

Alma Health Platform

Resellers

Not specified

Countries present

2

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Customizable plans, Subscription

Based on

Customizable plans, Number of analyses, Number of installations

Source: Vendor | First published: Sep 10, 2023 | Last updated: May 11, 2026

Neurocloud SISCOM - Qubiotech